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Assessing trends in long-term cancer patient survival is an essential component of monitoring progress against cancer by cancer
registries. Traditional assessment of long-term survival (‘cohort analysis’) is very useful to disclose trends in long-term survival rates of
patients diagnosed many years ago, but it does not allow the disclosure of recent trends in long-term survival rates. The latter can be
achieved by an alternative method of survival analysis (‘period analysis’), which has been proposed a few years ago. On the other
hand, unlike cohort analysis, period analysis does not provide estimates of long-term survival rates for patients diagnosed in the early
years after initiation of cancer registration. In this paper, a method of retrospective analysis of time trends in long-term survival rates is
introduced, which combines the advantages of both cohort and period analysis (‘mixed analysis’). This method thereby allows for a
comprehensive monitoring of trends in long-term survival over an extended time span from the earliest to the most recent years of
cancer registration. The use of the method is illustrated for retrospective time trend analyses of long-term survival of cancer patients
in the United States with the 1973–1999 database of the Surveillance, Epidemiology, and End Results Program of the National
Cancer Institute.
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Monitoring trends in long-term cancer patient survival rates is an
essential component of cancer surveillance. Long-term cancer
survival statistics are now reported by an increasing number of
cancer registries around the world (e.g., Sankaranarayanan et al,
1998; Berrino et al, 1999). In the past, long-term survival rates have
mostly been calculated in a ‘cohortwise’ manner, that is, for
cohorts of patients diagnosed in certain calendar years for whom
long-term follow-up, such as 5-, 10-, or 20-year follow-up, has been
completed in the meantime. Cohortwise analyses are very useful
for retrospective analyses of survival trends among those cohorts
of patients, but they cannot be applied to more recently diagnosed
patients for whom long-term follow-up is not yet available.
To provide more recent estimates of long-term survival, an
alternative method, denoted ‘period analysis’, has been proposed a
couple of years ago (Brenner and Gefeller, 1996, 1997). With this
method, recent survival estimates can be obtained by restricting
the analysis to the survival experience of patients within some
recent time interval (which is achieved by left truncation of
observations at the beginning of that interval in addition to right
censoring at its end). Period estimates derived in that way quite
closely predict long-term survival rates observed many years later
for patients diagnosed in the period of interest, thereby enabling
early detection of recent trends (Brenner and Hakulinen, 2002a,b;
Brenner et al, 2002b). On the other hand, period estimates of long-
term survival cannot be derived for the first years after initiation of
cancer registration, as their derivation requires that the database
includes patients who have been under long-term observation in
the period of interest.
In this paper, a method of retrospective analysis of time trends
in long-term survival rates is introduced, which combines the
advantages of cohort and period analysis (‘mixed analysis’). This
method thereby allows for a comprehensive monitoring of trends
in long-term survival over an extended time span from the earliest
to the most recent years of cancer registration.
METHODS AND RESULTS
Time trend analysis of long-term cancer survival rates with
the 1973–1999 SEER database
The method is illustrated for retrospective analyses of trends in
long-term survival of cancer patients in the United States with the
1973–1999 database of the Surveillance, Epidemiology, and
End Results Program of the National Cancer Institute (SEER,
2002). The SEER Program is the most authoritative source of
information on cancer incidence and survival in the United States,
and it is considered as the standard for quality among cancer
registries around the world. Data included in the 1973–1999 SEER
database are from nine population-based cancer registries, which
together cover a population of about 24 million people (SEER,
2002).
The different approaches to retrospective time trend analyses of
10-year survival rates as applied to the 1973–1999 SEER database
are illustrated in Table 1. Whereas traditional cohort analysis Received 30 May 2003; revised 28 July 2003; accepted 5 August 2003
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patients diagnosed between 1973 and 1989 only, the applicability of
period analysis is restricted to the years from 1983 to 1999. For
those years, period analysis provides the most up-to-date estimates
of 10-year survival that would have been available within each
year. In retrospective trend analyses, however, the empirically
demonstrated use of period estimates for a given calendar year as a
surrogate for the survival rates later observed for patients
diagnosed in that year (Brenner and Hakulinen, 2002b; Brenner
et al, 2002b) may only be meaningful for those calendar years for
which cohort estimates are not available. In our example, this
would pertain to the calendar years from 1990 to 1999.
Furthermore, some part of the survival function may be estimated
by cohort analysis even for patients diagnosed in those calendar
years. In fact, except for the year 1999, period analysis would only
be needed for completing the survival function over the full 10
years of interest. Hence, a combination of cohort analysis and
period analysis in a ‘mixed analysis’ may be useful for retro-
spective trend analysis of long-term survival (see the two columns
on the right-hand side of Table 1).
For example, an estimate of 10-year survival for patients
diagnosed in 1990 may be obtained by combining their survival
experience during the first 9 years following diagnosis, which can
be obtained by cohort analysis, with the most recent (1999) period
estimate of conditional survival for the 10th year following
diagnosis. That is, survival in the 10th year would be estimated
using survival experience in the 10th year of follow-up in 1999 of
patients diagnosed in 1989 and 1990. Similarly, 10-year survival for
patients diagnosed in 1991 may be estimated by combining their
survival experience during the first 8 years following diagnosis,
which is obtained by cohort analysis, with the most recent (1999)
period estimates of conditional survival for the 9th and the 10th
year following diagnosis. For more recent cohorts, an increasing
part of the survival function has to be obtained by period analysis,
and the 10-year survival estimate for the 1999 cohort is exclusively
obtained by period analysis. Thus, while a retrospective time trend
analysis by cohort and period analysis would be restricted to the
17-year time intervals 1973–1989 and 1983–1999, respectively,
‘mixed analysis’ allows a comprehensive time trend analysis over
the full 27-year time span from 1973 to 1999.
Obviously, the value of ‘mixed analysis’ increases with increas-
ing length of the follow-up of patients (see Table 2). For example,
analyses of 15-year survival rates by cohort and period analysis
would provide time trends for nonoverlapping 12-year time
intervals from 1973 to 1984 and from 1988 to 1999 only,
respectively. Analyses of trends in 20-year survival rates would
even be restricted to 7-year time intervals with cohort analysis
(1973–1979) and period analysis (1993–1999), whereas a trend
analysis of long-term survival over the full 27 years can only be
obtained by mixed analysis for all types of survival estimates.
Empirical examples
The different types of analyses are illustrated for time trends in 5-,
10-, 15-, and 20-year survival rates of patients with one of three
very common forms of cancer (colon cancer, lung cancer, breast
cancer) in the United States using the 1973–1999 SEER database.
In addition, analyses are shown for patients with testicular cancer,
as this cancer typically occurs at a relatively young age, in which
case long-term survival rates are of particularly high interest. Data
are presented for all races, all ages, and (for colon and lung cancer)
both sexes combined. Patients with a prior diagnosis of cancer
were excluded, as were patients whose cancer was known by death
certificate only (less than 2% for all types of cancer included in this
analysis) or by autopsy only (less than 1% for all types of cancer
included in this analysis).
Table 1 Analysis of time trends in 10-year survival rates in 1973–1999 by cohort, period, and mixed analysis
Cohort analysis Period analysis Mixed analysis
Calendar year Year of diagnosis Survival experience Year of diagnosis Survival experience Cohort analysis
a Period analysis
a
1973 1973 1973–1983 1–10
1974 1974 1974–1984 1–10
1975 1975 1975–1985 1–10
1976 1976 1976–1986 1–10
1977 1977 1977–1987 1–10
1978 1978 1978–1988 1–10
1979 1979 1979–1989 1–10
1980 1980 1980–1990 1–10
1981 1981 1981–1991 1–10
1982 1982 1982–1992 1–10
1983 1983 1983–1993 1973–1983 1983 1–10
1984 1984 1984–1994 1974–1984 1984 1–10
1985 1985 1985–1995 1975–1985 1985 1–10
1986 1986 1986–1996 1976–1986 1986 1–10
1987 1987 1987–1997 1977–1987 1987 1–10
1988 1988 1988–1998 1978–1988 1988 1–10
1989 1989 1989–1999 1979–1989 1989 1–10
1990 1980–1990 1990 1–9 10
1991 1981–1991 1991 1–8 9–10
1992 1982–1992 1992 1–7 8–10
1993 1983–1993 1993 1–6 7–10
1994 1984–1994 1994 1–5 6–10
1995 1985–1995 1995 1–4 5–10
1996 1986–1996 1996 1–3 4–10
1997 1987–1997 1997 1–2 3–10
1998 1988–1998 1998 1 2–10
1999 1989–1999 1999 1–10
aEach column contains the range of years after diagnosis for which survival estimates were contributed by either cohort or period analysis; the cohort analysis part is derived from
the cohort of patients diagnosed in the calendar year given in the leftmost column, whereas the period analysis part refers to survival experience in the calendar year 1999 in all
cases.
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survival rates. The relative survival rates reflect ‘net survival’ of
patients with cancer. They can be interpreted as the expected
survival experience of cancer patients in the hypothetical situation
in which the particular cancer is the only cause of death (Ederer
et al, 1961). The relative survival rates are calculated as the ratio of
absolute survival rates of cancer patients divided by the expected
survival rates of a group of patients of the corresponding age and
sex in the general population. Estimates of expected survival rates
were derived from pertinent population life tables according to
Hakulinen’s (1982) method.
Trends in 5-, 10-, 15-, and 20-year survival rates of colon cancer
patients as estimated by cohort analysis (solid black lines) and
period analysis (solid grey lines) are shown in Figure 1. Both cohort
and period analyses indicate an upward trend in long-term survival
rates in 1973–1999, but evidence from cohort analysis is restricted
to patients diagnosed in the earlier years, whereas evidence from
period analysis is restricted to the later years. Only for the 5- and 10-
year survival trends, there is some overlap of the time frame
encompassed by both approaches. Within those overlapping time
intervals, estimates from cohort and period analysis are in general
quite close, with a tendency towards slightly lower estimates from
period analysis as expected from both theory and previous extensive
empirical evaluation (Brenner and Hakulinen, 2002b; Brenner et al,
2002b). This means that an analysis of long-term survival conducted
by period analysis in those years would have underestimated
survival as estimable by now only slightly.
A more comprehensive picture of time trends in long-term
survival rates of patients with colon cancer is provided by mixed
analysis, which combines elements of both cohort and period
analysis as outlined in Tables 1 and 2. With this approach, trend
curves are available over the entire 1973–1999 time span, as
indicated by the dotted extensions of the black trend lines up to
and including the year 1999 (in which mixed analysis is equal to
period analysis by definition). This analysis demonstrates that
long-term relative survival rates of patients with colon cancer have
substantially increased over time until the middle of the 1980s,
whereas long-term relative survival estimates have remained rather
constant (at levels slightly above 60% for 5-year survival, and
between 50 and 60% for 10-, 15-, and 20-year survival) for patients
diagnosed in later years.
Figures 2–4 show analogous analyses of time trends in 5-, 10-,
15-, and 20-year relative survival rates of patients with lung, breast,
and testicular cancer.
Table 2 Calendar years for which 5-, 10-, 15-, and 20-year survival rates
can be obtained by cohort, period, and mixed analysis using the 1973–
1999 SEER database
Cohort analysis Period analysis Mixed analysis
5-year survival 1973–1994 1978–1999 1973–1999
10-year survival 1973–1989 1983–1999 1973–1999
15-year survival 1973–1984 1988–1999 1973–1999
20-year survival 1973–1979 1993–1999 1973–1999
1970 1980 1990 2000
Calendar year
100
80
60
40
20
0
5-year relative survival (%)
1970 1980 1990 2000
Calendar year
100
80
60
40
20
0
10-year relative survival (%)
1970 1980 1990 2000
Calendar year
100
80
60
40
20
0
20-year relative survival (%)
1970 1980 1990 2000
Calendar year
100
80
60
40
20
0
15-year relative survival (%)
Figure 1 Trends in 5-, 10-, 15-, and 20-year relative survival rates of
patients with a first diagnosis of colon cancer in the United States according
to cohort analysis (solid black lines), period analysis (solid grey lines), and
mixed analysis (dotted extension of black lines). SEER 1973–1999
database, all races, both sexes combined.
1970 1980 1990 2000
Calendar year
100
80
60
40
20
0
5-year relative survival (%)
1970 1980 1990 2000
Calendar year
100
80
60
40
20
0
10-year relative survival (%)
1970 1980 1990 2000
Calendar year 
100
80
60
40
20
0
20-year relative survival (%)
1970 1980 1990 2000
Calendar year 
100
80
60
40
20
0
15-year relative survival (%)
Figure 2 Trends in 5-, 10-, 15-, and 20-year relative survival rates of
patients with a first diagnosis of lung cancer in the United States according
to cohort analysis (solid black lines), period analysis (solid grey lines), and
mixed analysis (dotted extension of black lines). SEER 1973–1999
database, all races, both sexes combined.
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decades, and it continues to be very poor (see Figure 2). As
expected from theory (Brenner and Gefeller, 1996, 1997), in this
situation cohort and period analyses as well as mixed analysis yield
virtually identical estimates for those calendar years for which
more than one estimate can be obtained. However, mixed analysis
is the only approach that allows for a comprehensive retrospective
analysis of the time trends over the past decades.
For breast cancer, a clearly distinct picture emerges (see
Figure 3). The overall levels of survival have always been much
higher than for both colon and lung cancer, and they further
improved over time. On the other hand, the gradient from 5- to 10-
to 15- and 20-year relative survival rates is particularly large for
this form of cancer, which reflects the relatively high proportion of
late cancer deaths among women with breast cancer. Our trend
analysis shows that a major improvement in long-term prognosis
began with patients diagnosed in the early 1980s. According to the
latest cohort estimates as well as the latest period estimates of 5-
year survival, the pace of improvement, however, seems to have
levelled off in recent years. For patients diagnosed during the years
following the onset of rapid improvement, period estimates
available then would have somewhat lagged behind the long-term
survival rates observed for patients diagnosed in those years many
years later, as indicated by their discrepancy from both cohort and
mixed estimates. By contrast, the different types of estimates are
quite close for the years before the onset and after the levelling off
of major improvement.
With respect to testicular cancer, patients diagnosed in the
1980s and 1990s have experienced much higher long-term survival
rates than patients diagnosed in the 1970s (see Figure 4). For this
form of cancer, 5- and 10-year survival rates around 95% and 15-
and 20-year survival rates around 90% have now been achieved.
Cohort analysis alone would clearly demonstrate the rapid increase
in survival rates of patients diagnosed in the earlier years included
in this database, whereas period analysis shows the continuously
high levels of survival maintained in the more recent years. Again,
the most comprehensive picture of the time trends is provided by
mixed analysis.
For the sake of clarity, only point estimates of relative survival
are shown in Figures 1–4. With the exception of testicular cancer,
the standard errors of these estimates are generally small. Standard
errors for all estimates of 5-, 10-, 15-, and 20-year survival are
p0.9, p1.1, p1.3, and p1.6% for colon cancer, p0.4, p0.4,
p0.5, and p0.5% for lung cancer, p0.7, p0.8, p0.9, and p1.0%
for breast cancer, and p3.0, p3.2, p3.5, and p3.8% for testicular
cancer, respectively.
DISCUSSION
This paper illustrates how traditional cohort analysis and the more
recently introduced period analysis (Brenner and Gefeller, 1996,
1997) can be combined to extend retrospective time trend analyses
of long-term survival rates. The resulting ‘mixed analysis’ allows a
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0
Figure 3 Trends in 5-, 10-, 15-, and 20-year relative survival rates of
female patients with a first diagnosis of breast cancer in the United States
according to cohort analysis (solid black lines), period analysis (solid grey
lines), and mixed analysis (dotted extension of black lines). SEER 1973–
1999 database, all races combined.
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Figure 4 Trends in 5-, 10-, 15-, and 20-year relative survival rates of
patients with a first diagnosis of testicular cancer in the United States
according to cohort analysis (solid black lines), period analysis (solid grey
lines), and mixed analysis (dotted extension of black lines). SEER 1973–
1999 database, all races combined.
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prognosis of cancer patients from the earliest to the most recent
years of cancer registration.
Retrospective analyses of trends in long-term survival rates
over extended time intervals are performed from time to time by
many cancer registries with a long history of registration (e.g.,
Adami et al, 1989; Nab et al, 1994; Wingo et al, 1998; Dickman et al,
1999). Typically, such time trend analyses should provide a
comprehensive evaluation of time trends encompassing the
broadest possible time span from the earliest to the most recent
years of cancer registration. This is the context in which ‘mixed
analysis’ should be most useful. For other purposes, preferences
may be different. For example, ‘pure cohort analysis’ is entirely
sufficient, and there is no need of extension, for ‘historical’
assessment of long-term prognosis of cohorts of patients who have
been under observation over the full follow-up time of interest. On
the other hand, ‘pure period analysis’ might be the preferred
method for concurrent monitoring of very recent time trends in
long-term survival as well as for deriving the most up-to-date
estimates of long-term survival rates at a given time. Period
analysis has meanwhile been applied for the latter purpose in
different cancer registries (e.g., Brenner et al, 1998, 1999, 2001;
Brenner and Hakulinen, 2001; Aareleid and Brenner, 2002;
Brenner, 2002; Smith et al, 2003), whereas mixed analysis has,
with very few exceptions (Kaatsch et al, 2000; Burkhardt-Hammer
et al, 2002), not been applied to analyses of time trends in long-
term cancer patient survival so far.
Another option that has been employed in traditional survival
analysis is to include right-censored observations of patients, who
have not been observed over the full follow-up time of interest, in
the most recent estimates of long-term survival. For example, with
this approach, which has been called ‘complete analysis’ (Brenner
and Gefeller, 1997) and which has often been used in analyses of
the SEER database (e.g., Wingo et al, 1998), the most recent 10-
year estimates of survival could have been obtained from all
patients diagnosed in 1989 or later years rather than from patients
diagnosed in 1989 only in our analysis. However, while frequently
used for deriving single recent estimates of long-term survival,
complete analyses are usually not used for retrospective assess-
ment of time trends, which have almost exclusively relied on
cohort analysis in the past. Furthermore, although complete
analysis would have led to a somewhat more up-to-date (and also
somewhat more precise) most recent estimate of 10-year survival
compared to the one obtained with ‘pure cohort analysis’, it would,
unlike period analysis or mixed analysis, not have allowed
additional analyses of time trends in 10-year survival rates within
the 1989–1999 interval.
Although estimates from period analysis available at a given
point of time are more up-to-date than traditional estimates of
long-term survival rates available at the same point of time, even
the period estimates may tend to be somewhat too low in case of a
very rapid increase in survival over time (in such a case, the period
estimates may ‘lag somewhat behind’ the most recent develop-
ments, which become known later). These patterns have been
shown by extensive empirical evaluation in previous work
(Brenner and Hakulinen, 2002a,b; Brenner, 2003), and they were
seen for patients diagnosed with breast cancer in the 1980s in the
examples shown in this paper. For example, the major increase in
the survival of breast cancer patients in the 1980s would only have
been disclosed with substantial delay by period analysis had it
been performed then (albeit the delay would have been less severe
than with traditional survival analysis conducted at that time). In
retrospective analyses, estimates from mixed analysis are always
the most up-to-date estimates, as they include as much of the
actual survival experience of past cohorts as possible. For more
recent years, a large part of the mixed estimate is based on period
analysis, and mixed analysis and period analysis are the same for
the most recently diagnosed patients.
Like other methods of monitoring survival over time, period
analysis and mixed analysis do not by themselves reveal
the reasons for the increase of survival rates over time. Such
reasons may include advancements in therapy as well as earlier
detection (in the latter case increases in long-term survival have
to be interpreted with caution, as they may occur even if
early detection is ineffective in preventing cancer deaths).
Obviously, reasons do vary by cancer site. For example, the
increase in survival observed for patients with testicular cancer
is likely to be mainly due to a breakthrough in therapy (in
particular, the inclusion of cis-platin in chemotherapy schemes)
(Bosl and Motzer, 1997), whereas the increase in survival rates of
patients with breast cancer might reflect both earlier detection and
improved therapy (Hermon and Beral, 1996). More detailed
analyses, taking additional factors such as stage at diagnosis,
treatment, etc. into account, may help to further differentiate
possible reasons. Such analyses could be carried out with period
analysis and with mixed analysis in the same way as with
traditional cohortwise survival analysis.
Another issue to be considered in time trend analyses of long-
term survival rates is age adjustment of survival rates. On average,
cancer patients have become older over the past decades in most
countries. As prognosis of patients tends to vary with age for most
cancers, trends in crude (unadjusted) survival rates may not
adequately disclose the true progress in long-term survival rates
over time. This particularly applies to time trends over very long
time spans within which ‘ageing’ of the cancer populations may be
substantial. The issue is of much less concern for relative survival
rates that are presented in this paper than for absolute survival
rates, as the former vary much less with age than the latter.
However, where necessary, age adjustment is as easily carried out
in period and mixed analysis as in cohort analysis.
In summary, the combination of traditional cohortwise analysis
with period analysis in the form of mixed analysis may be a useful
tool for comprehensive retrospective monitoring of time trends in
long-term cancer patient survival from the earliest to the most
recent years of cancer registration. Recent development of
pertinent user-friendly software (Brenner et al, 2002a) should
facilitate widespread implementation of this new approach by
cancer registries.
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